跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,118 条关于
“Renalys Pharma”
全部
18,118
临床试验
12,364
药物
1,155
机构
1,226
资讯
3,373
11个月前
Chugai Pharmaceutical Acquires Renalys Pharma for $98 Million to Expand Kidney Disease Portfolio
去年
Renalys Pharma Completes Enrollment in Phase III Trial of Sparsentan for IgA Nephropathy in Japan
11个月前
Renalys Completes Primary Endpoint Data Collection for Sparsentan Phase III Trial in Japanese IgA Nephropathy Patients
6个月前
R1 Therapeutics Launches with $77.5M to Develop Novel Kidney Disease Treatment
2个月前
Alport Syndrome Market Projected to Surge at 47% CAGR Through 2036, Fueled by Emerging Disease-Modifying Therapies
上个月
Royalty Pharma and Zealand Pharma enter $100 million rusfertide funding agreement
去年
FDA Approves Verona Pharma's Ohtuvayre (ensifentrine) for COPD Maintenance
去年
Nxera Pharma Partners with Holling Bio-Pharma to Launch Daridorexant for Insomnia in Taiwan
去年
Calluna Pharma Appoints Mark Gaffney as CEO, Advances CAL101 Program
上个月
Fierce Pharma Week Europe Launches in Basel for 2027, Targeting Cross-Functional Pharma Leadership
第 1 页,共 338 页
上一页
下一页